TECENTRIQ CONCENTRATE FOR SOLUTION FOR INFUSION 1200 MG/ 20 ML
Product details
Registration number: SIN15425P
Classification: Prescription Only
Active ingredients: Atezolizumab
Strength: 1200 mg
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Registrant: ROCHE SINGAPORE PTE. LTD.
ATC code: L01FF05
HSA approval date: 9 February 2018
Manufacturer(s):
- Roche Diagnostics GmbH
- F. Hoffmann-La Roche Ltd
Manufacturing country/countries: SWITZERLAND; GERMANY
What are the HSA registration number and classification for TECENTRIQ CONCENTRATE FOR SOLUTION FOR INFUSION 1200 MG/ 20 ML?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15425P
Classification: Prescription Only
What active ingredients and strength are recorded for TECENTRIQ CONCENTRATE FOR SOLUTION FOR INFUSION 1200 MG/ 20 ML?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Atezolizumab
Strength: 1200 mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for TECENTRIQ CONCENTRATE FOR SOLUTION FOR INFUSION 1200 MG/ 20 ML?
According to the HSA dataset updated 7 August 2026:
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Who is the recorded registrant for TECENTRIQ CONCENTRATE FOR SOLUTION FOR INFUSION 1200 MG/ 20 ML?
According to the HSA dataset updated 7 August 2026:
Registrant: ROCHE SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for TECENTRIQ CONCENTRATE FOR SOLUTION FOR INFUSION 1200 MG/ 20 ML?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Roche Diagnostics GmbH
- F. Hoffmann-La Roche Ltd
Manufacturing country/countries: SWITZERLAND; GERMANY
Where can I look up TECENTRIQ CONCENTRATE FOR SOLUTION FOR INFUSION 1200 MG/ 20 ML in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15425P or the exact product name TECENTRIQ CONCENTRATE FOR SOLUTION FOR INFUSION 1200 MG/ 20 ML. The general register link does not preselect this product.
What are the source dates for this TECENTRIQ CONCENTRATE FOR SOLUTION FOR INFUSION 1200 MG/ 20 ML record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this TECENTRIQ CONCENTRATE FOR SOLUTION FOR INFUSION 1200 MG/ 20 ML record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15425P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)